Literature DB >> 28503978

Comparison of depression symptoms between primary depression and secondary-to-schizophrenia depression.

Twana Rahim1, Roshe Rashid2.   

Abstract

OBJECTIVES: This study exclusively aimed to clinically assess which symptom pattern discriminates primary depression from depression-secondary to-schizophrenia.
METHODS: A total of 98 patients with primary depression and 71 patients with secondary-to-schizophrenia depression were assessed for identifying the clinical phenomena of depression. Diagnosis of schizophrenia was confirmed by Mini International Neuropsychiatric Interview. Each participant was, however, assessed by Patient Health Questionnaire-9 as well as Calgary Depression Scale for Schizophrenia (CDSS) for possible concurrent depressive symptoms.
RESULTS: Depressed mood, loss of interest, reduced energy and pathological guilt were more common in primary depression, whereas sleep disturbance and guilty ideas of reference were more amounting towards the diagnosis of depression secondary-to-schizophrenia.
CONCLUSIONS: It is clinically hard to differentiate primary from secondary-to-schizophrenia depression, especially in the absence of obvious psychotic symptoms. However, the classical symptoms of depression like subjective depressed mood, anhedonia, reduced energy and pathological guilt are more prominent in the primary depression.

Entities:  

Keywords:  Depression; common symptoms; schizophrenia

Mesh:

Year:  2017        PMID: 28503978     DOI: 10.1080/13651501.2017.1324036

Source DB:  PubMed          Journal:  Int J Psychiatry Clin Pract        ISSN: 1365-1501            Impact factor:   1.812


  10 in total

1.  Association of APOE E2 and low-density lipoprotein with depressive symptoms in Chinese senile schizophrenia inpatients: A cross-sectional study.

Authors:  Wei Li
Journal:  Schizophr Res Cogn       Date:  2020-11-19

2.  miR-9 inhibition of neuronal apoptosis and expression levels of apoptosis genes Bcl-2 and Bax in depression model rats through Notch pathway.

Authors:  Peng Xiao; Xiaoming Zhang; Yanfei Li; Zhongyi Ma; Shuping Si; Xinxue Gao
Journal:  Exp Ther Med       Date:  2019-11-21       Impact factor: 2.447

3.  EPA guidance on assessment of negative symptoms in schizophrenia.

Authors:  S Galderisi; A Mucci; S Dollfus; M Nordentoft; P Falkai; S Kaiser; G M Giordano; A Vandevelde; M Ø Nielsen; L B Glenthøj; M Sabé; P Pezzella; I Bitter; W Gaebel
Journal:  Eur Psychiatry       Date:  2021-02-18       Impact factor: 5.361

4.  Depression and Obsessive-Compulsive Disorders Amid the COVID-19 Pandemic in Saudi Arabia.

Authors:  Noara AlHusseini; Muhammad Sajid; Afaf Altayeb; Shahd Alyousof; Haifa Alsheikh; Abdulrahman Alqahtani; Afrah Alsomali
Journal:  Cureus       Date:  2021-01-28

5.  Efficacy and safety of Qigong Baduanjin exercise in the treatment of depression with insomnia: A randomized controlled study protocol.

Authors:  Jing Fan; Fangmin Qian; Qingqing Wang; Bihua Chen; Linchuang Wang
Journal:  Medicine (Baltimore)       Date:  2021-11-24       Impact factor: 1.817

6.  Prevalence, Influencing Factors, and Cognitive Characteristics of Depressive Symptoms in Elderly Patients with Schizophrenia.

Authors:  Yaopian Chen; Wei Li
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-14       Impact factor: 2.570

7.  Depressive Symptoms and PANSS Symptom Dimensions in Patients With Predominant Negative Symptom Schizophrenia: A Network Analysis.

Authors:  Koen Demyttenaere; Elizabeth Anthonis; Károly Acsai; Christoph U Correll
Journal:  Front Psychiatry       Date:  2022-04-25       Impact factor: 4.157

8.  Exploring the mechanisms of action of Cordyceps sinensis for the treatment of depression using network pharmacology and molecular docking.

Authors:  Xingfang Zhang; Mengyuan Wang; Yajun Qiao; Zhongshu Shan; Mengmeng Yang; Guoqiang Li; Yuancan Xiao; Lixin Wei; Hongtao Bi; Tingting Gao
Journal:  Ann Transl Med       Date:  2022-03

9.  Interpersonal Guilt and Problematic Online Behaviors: The Mediating Role of Emotion Dysregulation.

Authors:  Angela Russo; Gianluca Santoro; Adriano Schimmenti
Journal:  Clin Neuropsychiatry       Date:  2022-08

10.  The prevalence and associated factors of depression among patients with schizophrenia in Addis Ababa, Ethiopia, cross-sectional study.

Authors:  Tolesa Fanta; Desalegn Bekele; Getinet Ayano
Journal:  BMC Psychiatry       Date:  2020-01-02       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.